相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions
Nathaniel J. Hart et al.
DIABETOLOGIA (2019)
The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations
Amin Ardestani et al.
ENDOCRINE REVIEWS (2018)
A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
T. Azad et al.
NATURE COMMUNICATIONS (2018)
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Miguel Martin et al.
LANCET ONCOLOGY (2017)
Analysis of Purified Pancreatic Islet Beta and Alpha Cell Transcriptomes Reveals 11β-Hydroxysteroid Dehydrogenase (Hsd11b1) as a Novel Disallowed Gene
Timothy J. Pullen et al.
FRONTIERS IN GENETICS (2017)
Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis
Nouha Ben-Othman et al.
CELL (2017)
Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor
Shruti Rakesh Tiwari et al.
CLINICAL BREAST CANCER (2016)
β-cell differentiation status in type 2 diabetes
Nicola Jeffery et al.
DIABETES OBESITY & METABOLISM (2016)
MST1: a promising therapeutic target to restore functional beta cell mass in diabetes
Amin Ardestani et al.
DIABETOLOGIA (2016)
Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes
Francesca Cinti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Arlene Chan et al.
LANCET ONCOLOGY (2016)
Characterization of Hippo Pathway Components by Gene Inactivation
Steven W. Plouffe et al.
MOLECULAR CELL (2016)
Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
Fuqin Fan et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Definition of a Skp2-c-Myc Pathway to Expand Human Beta-cells
Shiwani Tiwari et al.
SCIENTIFIC REPORTS (2016)
Proproliferative and antiapoptotic action of exogenously introduced YAP in pancreatic β cells
Ting Yuan et al.
JCI INSIGHT (2016)
Exploiting Expression of Hippo Effector, Yap, for Expansion of Functional Islet Mass
Nicholas M. George et al.
MOLECULAR ENDOCRINOLOGY (2015)
Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?
Athanasios Fountas et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Benchmark datasets for 3D MALDI- and DESI-imaging mass spectrometry
Janina Oetjen et al.
GIGASCIENCE (2015)
Pdx1 Maintains β Cell Identity and Function by Repressing an α Cell Program
Tao Gao et al.
CELL METABOLISM (2014)
Are we overestimating the loss of beta cells in type 2 diabetes?
Lorella Marselli et al.
DIABETOLOGIA (2014)
MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes
Amin Ardestani et al.
NATURE MEDICINE (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Targeting the pancreatic β-cell to treat diabetes
Amedeo Vetere et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Genetic Deletion of Mst1 Alters T Cell Function and Protects against Autoimmunity
Konstantin V. Salojin et al.
PLOS ONE (2014)
Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes
Patricia O. Prada et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
BASIC AND TRANSLATIONAL-PANCREAS
Tao Gao et al.
GASTROENTEROLOGY (2013)
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Chutima Talchai et al.
CELL (2012)
Hippo Signaling Regulates Pancreas Development through Inactivation of Yap
Nicholas M. George et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
In Vitro Proliferation of Adult Human Beta-Cells
Sabine Rutti et al.
PLOS ONE (2012)
Protein kinases of the Hippo pathway: Regulation and substrates
Joseph Avruch et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size
Mei Xin et al.
SCIENCE SIGNALING (2011)
c-Jun N-terminal Kinase Enhances MST1-mediated Pro-apoptotic Signaling through Phosphorylation at Serine 82
Wenzhi Bi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
When pathways collide: collaboration and connivance among signalling proteins in development
Helen McNeill et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Immunocytochemical localisation of caspase-3 in pancreatic islets from type 2 diabetic subjects
Tatsuo Tomita
PATHOLOGY (2010)
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Hai Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of genes selectively disallowed in the pancreatic islet
Timothy J. Pullen et al.
ISLETS (2010)
CXCL10 Impairs β Cell Function and Viability in Diabetes through TLR4 Signaling
Fabienne T. Schulthess et al.
CELL METABOLISM (2009)
Autophagy in human type 2 diabetes pancreatic beta cells
M. Masini et al.
DIABETOLOGIA (2009)
β-Cell-Specific Overexpression of Glutathione Peroxidase Preserves Intranuclear MafA and Reverses Diabetes in db/db Mice
Jamie S. Harmon et al.
ENDOCRINOLOGY (2009)
Neratinib: an oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer
Prithviraj Bose et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
A Cell-Intrinsic Role for Mst1 in Regulating Thymocyte Egress
Yongli Dong et al.
JOURNAL OF IMMUNOLOGY (2009)
Toward the Development of a Potent and Selective Organoruthenium Mammalian Sterile 20 Kinase Inhibitor
Ruchi Anand et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
Jianmin Zhang et al.
NATURE CELL BIOLOGY (2009)
Blosignaling of mammalian Ste20-related kinases
Pin Ling et al.
CELLULAR SIGNALLING (2008)
Pancreatic β-cell mass in European subjects with type 2 diabetes
J. Rahier et al.
DIABETES OBESITY & METABOLISM (2008)
PTP1B inhibitor Ertiprotafib is also a potent inhibitor of IκB kinase β (IKK-β)
Suja Shrestha et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Improvement of type 2 diabetes in a lung cancer patient treated with erlotinib
Daniel B. Costa et al.
DIABETES CARE (2006)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?
JJ Meier et al.
DIABETOLOGIA (2005)
Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms
DV Erbe et al.
MOLECULAR PHARMACOLOGY (2005)
Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase
WL Cheung et al.
CELL (2003)
beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
AE Butler et al.
DIABETES (2003)
β-cell death during progression to diabetes
D Mathis et al.
NATURE (2001)
Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function
K Maedler et al.
DIABETES (2001)
分享论文
